%0 Journal Article %1 amit_chirania_2023_7939941 %A Chirania, Amit %A Dilkhush, %A Sirvi, Prakash %A Ashok, %A Singh, Singh Gopal Nanu %A Joshi, Devendra %A Kumar, Jagdish %D 2023 %J World Journal of Biology Pharmacy and Health Sciences %K COVID-19 Diagnosis of %N 1 %P 162-167 %R 10.30574/wjbphs.2023.13.1.0222 %T COVID-19 (SARS-COV-2) structural features, pathophysiology and current drug therapy %U https://wjbphs.com/content/covid-19-sars-cov-2-structural-features-pathophysiology-and-current-drug-therapy %V 13 %X The 2019 coronavirus pandemic disease has spread globally. SARS-CoV-2 species in the first and second time waves and new species of Omicron show symptoms in the third wave of COVID-19 worldwide. The first patients were found in Wuhan, China. Due to COVID-19, the main highly infected countries are the U.S. China, European countries, and also India. The SARS-CoV-2 species are betacoronavirus infections that spread from person to person and another object. The COVID-19 SARS species (RNA virus) is majorly infected in the lungs. Some vaccines and some drugs are provided worldwide, but these vaccines are not proper treatment for COVID-19. These vaccines boost immunity and provide relief from the symptoms of COVID-19, but they are not a proper treatment. Antimalarial drugs, antiviral drugs, monoclonal antibodies, and antibiotics are used in the current treatment to stop mechanisms like fusion entry and replication. Identification of COVID-19 through symptoms and properly identified by RT-PCR Prevention and treatment of COVID-19 disease is a promising new research area for pharma companies to develop novel therapeutic agents' inhibition for COVID-19 pathological targets.

@article{amit_chirania_2023_7939941, abstract = {The 2019 coronavirus pandemic disease has spread globally. SARS-CoV-2 species in the first and second time waves and new species of Omicron show symptoms in the third wave of COVID-19 worldwide. The first patients were found in Wuhan, China. Due to COVID-19, the main highly infected countries are the U.S. China, European countries, and also India. The SARS-CoV-2 species are betacoronavirus infections that spread from person to person and another object. The COVID-19 SARS species (RNA virus) is majorly infected in the lungs. Some vaccines and some drugs are provided worldwide, but these vaccines are not proper treatment for COVID-19. These vaccines boost immunity and provide relief from the symptoms of COVID-19, but they are not a proper treatment. Antimalarial drugs, antiviral drugs, monoclonal antibodies, and antibiotics are used in the current treatment to stop mechanisms like fusion entry and replication. Identification of COVID-19 through symptoms and properly identified by RT-PCR Prevention and treatment of COVID-19 disease is a promising new research area for pharma companies to develop novel therapeutic agents' inhibition for COVID-19 pathological targets.}, added-at = {2023-07-17T03:16:49.000+0200}, author = {Chirania, Amit and Dilkhush and Sirvi, Prakash and Ashok and Singh, Singh Gopal Nanu and Joshi, Devendra and Kumar, Jagdish}, biburl = {https://www.bibsonomy.org/bibtex/215bf5df23dd77c5a18181e48cfc0818d/wjbphsjournal}, doi = {10.30574/wjbphs.2023.13.1.0222}, interhash = {16a7d914ddaf715b3d4d8a8cab6aec07}, intrahash = {15bf5df23dd77c5a18181e48cfc0818d}, issn = {2582-5542}, journal = {{World Journal of Biology Pharmacy and Health Sciences}}, keywords = {COVID-19 Diagnosis of}, month = jan, number = 1, pages = {162-167}, timestamp = {2023-07-17T03:16:49.000+0200}, title = {COVID-19 (SARS-COV-2) structural features, pathophysiology and current drug therapy}, url = {https://wjbphs.com/content/covid-19-sars-cov-2-structural-features-pathophysiology-and-current-drug-therapy}, volume = 13, year = 2023 }